Compare TECH & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | TXRH |
|---|---|---|
| Founded | 1976 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 12.3B |
| IPO Year | 1995 | 2004 |
| Metric | TECH | TXRH |
|---|---|---|
| Price | $72.68 | $183.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 28 |
| Target Price | $70.50 | ★ $208.29 |
| AVG Volume (30 Days) | ★ 2.7M | 1.3M |
| Earning Date | 11-17-2026 | 11-05-2026 |
| Dividend Yield | 0.44% | ★ 1.60% |
| EPS Growth | ★ 152.17 | N/A |
| EPS | 1.16 | ★ 3.72 |
| Revenue | ★ $1,215,039,000.00 | N/A |
| Revenue This Year | $4.38 | $10.90 |
| Revenue Next Year | $10.06 | $9.52 |
| P/E Ratio | $62.65 | ★ $50.24 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $43.20 | $153.83 |
| 52 Week High | $72.75 | $216.30 |
| Indicator | TECH | TXRH |
|---|---|---|
| Relative Strength Index (RSI) | 57.86 | 66.65 |
| Support Level | $72.11 | $179.82 |
| Resistance Level | $72.75 | $188.33 |
| Average True Range (ATR) | 0.11 | 5.34 |
| MACD | -0.00 | 2.83 |
| Stochastic Oscillator | 80.00 | 90.58 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches. Geographically, the majority of the firm's restaurants are in the USA, with a few in foreign countries.